Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response
- PMID: 3899472
Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response
Abstract
Warfarin maintenance-dose requirements predicted by six mathematical methods based on initial response to therapy were compared with patients' actual dose requirements in a multicenter trial. Data were collected for patients who had received an initial regimen of warfarin sodium 10 mg orally every 24 hours for three days and for whom a prothrombin time (PT) had been determined 16-20 hours after the third dose. Patients' individual dose requirements and PT values were recorded during one to three follow-up visits after discharge from one of seven medical centers. Prothrombin ratios (patient PT divided by control PT) calculated on day 4 were used for maintenance-dose prediction by five methods; a sixth method was based on the cumulative warfarin dose-PT response curve up to a PT value of 20 seconds. For 54 men and 30 women who qualified for the study, 197 maintenance-dose-PT response measurements were recorded; 95 in the first four weeks of therapy, 76 during weeks 5-12, and 26 at 6-12 months after initial treatment. Prothrombin ratios were within the therapeutic range (PT 1.5-2.5 times the control value) in 154 observations, and the mean actual warfarin sodium maintenance dose associated with therapeutic response was 7.6 mg/day. For patients with therapeutic prothrombin ratios, dose predictions by the five methods using prothrombin ratios (PRs) correlated significantly with actual dose requirements. The formula that predicted doses numerically closest to the actual dose is as follows: Dose = 11.17 - 21.08 (log PR). Only 45 observations were obtained for the sixth prediction method, and the correlation between actual and predicted doses was not significant. Initial warfarin maintenance-dose requirements can be predicted effectively based on one PT determination after administration of three daily 10-mg doses.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.Clin Pharm. 1987 Jan;6(1):37-45. Clin Pharm. 1987. PMID: 3816105 Clinical Trial.
-
Predicting warfarin maintenance dosage based on initial response.Am J Hosp Pharm. 1979 Oct;36(10):1351-5. Am J Hosp Pharm. 1979. PMID: 507078
-
Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.Clin Pharm. 1987 May;6(5):406-12. Clin Pharm. 1987. PMID: 3665392
-
The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.Thromb Haemost. 1986 Dec 15;56(3):371-5. Thromb Haemost. 1986. PMID: 3563968
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
Cited by
-
Anticoagulation control with warfarin by junior hospital doctors.J R Soc Med. 1988 Apr;81(4):246. doi: 10.1177/014107688808100432. J R Soc Med. 1988. PMID: 3373479 Free PMC article. No abstract available.
-
The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin.Ann Surg. 1987 Aug;206(2):155-61. doi: 10.1097/00000658-198708000-00007. Ann Surg. 1987. PMID: 3300580 Free PMC article. Clinical Trial.
-
Control of warfarin therapy.Postgrad Med J. 1989 Sep;65(767):611-2. doi: 10.1136/pgmj.65.767.611. Postgrad Med J. 1989. PMID: 2692014 Free PMC article. Review. No abstract available.
-
Dosage individualization of warfarin using artificial neural networks.Mol Diagn Ther. 2014 Jun;18(3):371-9. doi: 10.1007/s40291-014-0090-7. Mol Diagn Ther. 2014. PMID: 24574079
-
Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing.J Gen Intern Med. 1987 May-Jun;2(3):141-8. doi: 10.1007/BF02596140. J Gen Intern Med. 1987. PMID: 3295148 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials